Cara Therapeutics Inc (CARA): Growth-Adjusted Payback Ratio

Brandmark of Cara Therapeutics Inc (CARA)

Cara Therapeutics, Inc. (CARA) revenues are based on Korsuva sales and partnership payments. The adjusted P/E relative to growth rates demonstrates the asset's value dynamics, where 0.00 captures the current state of the parameter. Management is currently cutting costs following failed tests, while crisis management, under pressure from shareholders, is exploring new business development options.

Price/Earnings to Growth Multiple: Cara Therapeutics Inc. (CARA) for 07/04/2022 - 11/16/2026

Analytical breakdowns for Cara Therapeutics (CARA)

- stock value and consensus price forecast:
- stock exchange capitalization data:
General company analysis:CARA - Cara Therapeutics Inc
Brand item of caratherapeutics.com

The PEG ratio correlates the P/E ratio with earnings growth rates to determine whether an asset's market value is justified by its growth dynamics. Amidst the critical crisis facing Cara Therapeutics, Inc. (CARA) and the suspension of difelikefalin trials, the PEG fair value filter on GURU.Markets helps identify false undervaluation, where a low multiple masks the risk of total business liquidation due to the depletion of cash reserves.

Competitors of Cara Therapeutics, Inc.

Growth-Adjusted Market Cap to Net Income Biogen Idec|Neurocrine Corp - Price/Earnings to Growth Multiple|regencellbioscience.com (RGC) - Price to Earnings Adjusted for Growth Rate|AXSM - Price/Earnings to Growth Ratio|ACAD (ACADIA Pharmaceuticals Inc.) - Growth-Adjusted P/E Ratio|Xenon Pharmaceuticals (XENE) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio VKTX|Price/Earnings to Growth Ratio Supernus|Price to Earnings Adjusted for Growth Rate catalystpharma.com CPRX|Price/Earnings to Growth Multiple DNLI (Denali Therapeutics Inc.)|HRMY - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Biohaven Ltd. BHVN|AMLX (Amylyx) - Market Cap to Earnings and Growth Ratio|Trevi Therapeutics Inc - PEG Multiple|Growth-Adjusted Payback Ratio PRAX (Praxis Precision Medicines)|AVXL: PEG Multiple|CBLL - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio prothena.com|Price/Earnings to Growth Multiple Alector (ALEC)|Price/Earnings to Growth Multiple ANNX (annexonbio.com)|OMER - Price to Earnings Adjusted for Growth Rate|PEG Multiple NGNE (Neurogene Inc)|PEG Multiple AC Immune S.A. ACIU|VYGR - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMRA|SCLX (Scilex Holding Company) - Price/Earnings to Growth Multiple|TVGN (Tevogen Bio Holdings) - Price/Earnings to Growth Ratio|ACOG (Alpha Cognition Corp) - PEG Multiple|Cognition Therapeutics, Inc. - Market Cap to Earnings and Growth Ratio|PEG Multiple IKT|SAVA (Cassava) - Growth-Adjusted Payback Ratio|Assertio Holdings, Inc. - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio COYA|VistaGen Therapeutics, Inc. - PEG Multiple|Growth-Adjusted Market Cap to Net Income Ovid Therapeutics OVID|ABOS: PEG Multiple|CervoMed Corporation (CRVO) - PEG Multiple|Price/Earnings to Growth Ratio Alterity Therapeutics Limited|Price/Earnings to Growth Ratio CLNN|PEG Multiple PEPG|JUNS (Jupiter Neurosciences) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Relmada Corp RLMD|PEG Multiple Annovis Bio Corporation ANVS|gracetx.com - PEG Multiple|Firefly Neuroscience, Inc (AIFF) - Price/Earnings to Growth Multiple|Klotho Neurosciences (KLTO) - Price/Earnings to Growth Ratio|NeuroSense Therapeutics, Ltd. - Growth-Adjusted Payback Ratio|RVPH (Reviva Pharmaceuticals Holdings) - PEG Multiple|MetaVia Inc (MTVA) - Growth-Adjusted Market Cap to Net Income|PEG Multiple NRXS|Growth-Adjusted Market Cap to Net Income Helius Medical Technologies Inc.|Price/Earnings to Growth Ratio passagebio.com PASG|NEUP: Growth-Adjusted P/E Ratio|NERV - Price/Earnings to Growth Ratio|Athira - Company Value to Earnings Growth Ratio|ADXN: PEG Multiple|ALZN (Alzamend Neuro, Inc.) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Ratio Cyclerion Therapeutics Inc.|PTIX: Growth-Adjusted Payback Ratio|PEG Multiple KTTA|Company Value to Earnings Growth Ratio CRGT|Avenue Therapeutics Inc - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio BCLI|Chromocell Therapeutics Corp. - PEG Multiple|eliemtx.com - Company Value to Earnings Growth Ratio|Intra-Cellular Therapies (ITCI) - Price/Earnings to Growth Ratio|LBPH (Longboard) - Price/Earnings to Growth Ratio|MRNS (marinuspharma.com) - PEG Multiple|Price to Earnings Adjusted for Growth Rate NKGen Biotech NKGN|Price/Earnings to Growth Ratio NeuroBo Pharma (NRBO)|Company Value to Earnings Growth Ratio SAGE|Synaptogenix, Inc. - Price/Earnings to Growth Multiple|TRVN: Growth-Adjusted P/E Ratio|VIGL - Price/Earnings to Growth Ratio|Growth-Adjusted Payback Ratio WENA (Anew Medical, Inc.)|CERE: PEG Multiple